Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| DENTSPLY SIRONA Inc.XRAY · Entity 4448 | Director | June 15, 2026 | June 15, 2026 |
| Mondelez International, Inc.MDLZ · Entity 2953 | EVP & CFO | February 22, 2018 | February 26, 2018 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
DENTSPLY SIRONA Inc.
Report date June 15, 2026 · Filed June 15, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 61,848.544 |
Reported balance
After 2026-06-15 transaction · row 1
1 source rowRow 1 · 2026-06-15 · Purchase · Acquired 9,985.022 · Balance 61,848.544 F1: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $10.015 to 10.0156, inclusive. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. |
Filing footnotes · ownership attribution and instrument terms
F1: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $10.015 to 10.0156, inclusive. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
Mondelez International, Inc.
Report date February 22, 2018 · Filed February 26, 2018
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 194,565 |
Ending reported balance
After 2018-02-22 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2018-02-22 · Grant · Acquired 137,476 · Balance 252,106 F1: Shares of common stock received upon vesting of performance share units granted under the Issuer's Amended and Restated 2005 Performance Incentive Plan. Row 2 · 2018-02-22 · Tax withholding · Disposed 57,541 · Balance 194,565 F2: Withholding of shares of common stock to satisfy tax withholding obligations in connection with the vesting of performance share units. |
| Stock Options (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $43.51 · Expires 2028-02-22 | Direct | 135,030 |
Reported balance
After 2018-02-22 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2018-02-22 · Grant · Acquired 135,030 · Balance 135,030 F3: Options vest in three annual installments as follows: 33% on February 22, 2019; 33% on February 22, 2020; and 34% on February 22, 2021. |
Filing footnotes · ownership attribution and instrument terms
F1: Shares of common stock received upon vesting of performance share units granted under the Issuer's Amended and Restated 2005 Performance Incentive Plan.
F2: Withholding of shares of common stock to satisfy tax withholding obligations in connection with the vesting of performance share units.
F3: Options vest in three annual installments as follows: 33% on February 22, 2019; 33% on February 22, 2020; and 34% on February 22, 2021.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 15, 2026 Filed Jun 15, 2026 21:05 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | PurchaseCommon Stock | 9,985.022 | $10.02 | $100,000.00 |
DisclosureSEC source: 0000818479-26-000211 · form4.xml · nonDerivative · entry 1 Gladden Brian T · CIK 0001435432 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 61,848.544 F1 · price: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $10.015 to 10.0156, inclusive. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. Read SEC document |
| June 03, 2026 Filed Jun 5, 2026 21:31 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantCommon Stock | 22,822 | $0.00 | $0.00 |
DisclosureSEC source: 0000818479-26-000185 · form4.xml · nonDerivative · entry 1 Gladden Brian T · CIK 0001435432 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 51,863.522 F1 · shares: This grant consists entirely of Restricted Stock Units (RSUs) that vest in full (restrictions lapse) one year from date of grant. Read SEC document |
| January 09, 2026 Filed Jan 13, 2026 21:30 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantCommon Stock | 314.959 | $0.00 | $0.00 |
DisclosureSEC source: 0000818479-26-000030 · form4.xml · nonDerivative · entry 1 Gladden Brian T · CIK 0001435432 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,041.522 F1 · shares: Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis. Read SEC document |
| October 10, 2025 Filed Oct 15, 2025 20:38 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantCommon Stock | 286.094 | $0.00 | $0.00 |
DisclosureSEC source: 0000818479-25-000210 · form4.xml · nonDerivative · entry 1 Gladden Brian T · CIK 0001435432 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,726.563 F1 · shares: Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis. Read SEC document |
| July 11, 2025 Filed Jul 15, 2025 20:42 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantCommon Stock | 222.26 | $0.00 | $0.00 |
DisclosureSEC source: 0000818479-25-000125 · form4.xml · nonDerivative · entry 1 Gladden Brian T · CIK 0001435432 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,440.469 F1 · shares: Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis. Read SEC document |
| May 22, 2025 Filed May 27, 2025 21:19 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantCommon Stock | 13,880 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-015708 · form4.xml · nonDerivative · entry 1 Gladden Brian T · CIK 0001435432 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,218.209 F1 · shares: This grant consists entirely of Restricted Stock Units (RSUs) that vest in full (restrictions lapse) one year from date of grant. Read SEC document |
| April 11, 2025 Filed Apr 15, 2025 20:11 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantCommon Stock | 87.462 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-012073 · form4.xml · nonDerivative · entry 1 Gladden Brian T · CIK 0001435432 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,338.209 F1 · shares: Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis. Read SEC document |
| January 10, 2025 Filed Jan 14, 2025 22:03 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantCommon Stock | 119.378 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-001211 · form4.xml · nonDerivative · entry 1 Gladden Brian T · CIK 0001435432 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,250.747 F1 · shares: Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis. Read SEC document |
| October 11, 2024 Filed Oct 15, 2024 20:40 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantCommon Stock | 83.095 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-025507 · form4.xml · nonDerivative · entry 1 Gladden Brian T · CIK 0001435432 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,131.369 F1 · shares: Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis. Read SEC document |
| July 12, 2024 Filed Jul 15, 2024 20:53 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantCommon Stock | 89.658 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-020393 · form4.xml · nonDerivative · entry 1 Gladden Brian T · CIK 0001435432 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,048.274 F1 · shares: Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis. Read SEC document |
| May 23, 2024 Filed May 24, 2024 20:15 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantCommon Stock | 7,994 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-016565 · form4.xml · nonDerivative · entry 1 Gladden Brian T · CIK 0001435432 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,958.616 F1 · shares: This grant consists entirely of Restricted Stock Units (RSUs) that vest in full (restrictions lapse) one year from date of grant. Read SEC document |
| April 12, 2024 Filed Apr 15, 2024 23:22 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantCommon Stock | 28.616 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-012901 · form4.xml · nonDerivative · entry 1 Gladden Brian T · CIK 0001435432 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,964.616 F1 · shares: Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis. Read SEC document |
| February 26, 2024 Filed Feb 27, 2024 21:07 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantCommon Stock | 5,936 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-007143 · form4.xml · nonDerivative · entry 1 Gladden Brian T · CIK 0001435432 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,936 F1 · shares: This grant consists entirely of Restricted Stock Units (RSUs) that vest in full (restrictions lapse) one year from date of grant. Read SEC document |
| February 22, 2018 Filed Feb 26, 2018 22:29 UTC | Mondelez International, Inc. MDLZ · Entity 2953 | GrantStock Options (right to buy) · Derivative | 135,030 | $0.00 Strike: $43.51 | $0.00 |
DisclosureSEC source: 0001209191-18-013470 · doc4.xml · derivative · entry 3 Gladden Brian T · CIK 0001435432 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 135,030 Underlying: Class A Common Stock · 135,030 shares Expires 2028-02-22 F3 · derivative.exercise_date: Options vest in three annual installments as follows: 33% on February 22, 2019; 33% on February 22, 2020; and 34% on February 22, 2021. Read SEC document |
| February 22, 2018 Filed Feb 26, 2018 22:29 UTC | Mondelez International, Inc. MDLZ · Entity 2953 | Tax withholdingClass A Common Stock | 57,541 | $43.51 | $2,503,608.91 |
DisclosureSEC source: 0001209191-18-013470 · doc4.xml · nonDerivative · entry 2 Gladden Brian T · CIK 0001435432 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 194,565 F2 · shares: Withholding of shares of common stock to satisfy tax withholding obligations in connection with the vesting of performance share units. Read SEC document |
| February 22, 2018 Filed Feb 26, 2018 22:29 UTC | Mondelez International, Inc. MDLZ · Entity 2953 | GrantClass A Common Stock | 137,476 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-013470 · doc4.xml · nonDerivative · entry 1 Gladden Brian T · CIK 0001435432 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 252,106 F1 · shares: Shares of common stock received upon vesting of performance share units granted under the Issuer's Amended and Restated 2005 Performance Incentive Plan. Read SEC document |
| August 01, 2017 Filed Aug 2, 2017 20:31 UTC | Mondelez International, Inc. MDLZ · Entity 2953 | GrantClass A Common Stock | 114,630 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-047119 · doc4.xml · nonDerivative · entry 1 Gladden Brian T · CIK 0001435432 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 114,630 F1 · shares: Deferred stock units granted under the Issuer's Amended and Restated 2005 Performance Incentive Plan. Deferred stock units will vest as follows: 50% on August 1, 2020 and 50% on August 1, 2022. Read SEC document |
| February 16, 2017 Filed Feb 21, 2017 21:06 UTC | Mondelez International, Inc. MDLZ · Entity 2953 | GrantStock Options (right to buy) · Derivative | 136,000 | $0.00 Strike: $43.20 | $0.00 |
DisclosureSEC source: 0001209191-17-012619 · doc4.xml · derivative · entry 1 Gladden Brian T · CIK 0001435432 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 136,000 Underlying: Class A Common Stock · 136,000 shares Expires 2027-02-16 F1 · derivative.exercise_date: Options will vest in three annual installments as follows: 33% on February 16, 2018; 33% on February 16, 2019; and 34% on February 16, 2020. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.